E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma

Clinical trial NCT01133977 · COMPLETED

Trial details

NCT number: NCT01133977
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Melanoma

Start date: 2010-04-01
Primary completion: 2014-06-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.